Dr. Douglas Ditzel, DO

Radiation Oncology Englewood, OH Male
NPI: 1154381747
Total Payments
$2,573
2024 Payments
$190.03
Companies
39
Transactions
147
Medicare Patients
4,985
Medicare Billing
$2.1M

Payment Breakdown by Category

Food & Beverage$2,573 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,573 147 100.0%

Top Paying Companies

Company Total Records Latest Year
Pharmacyclics LLC, an AbbVie Company $234.60 12 $0 (2022)
Amgen Inc. $219.61 13 $0 (2022)
Novartis Pharmaceuticals Corporation $166.78 10 $0 (2024)
Celgene Corporation $161.38 9 $0 (2024)
Merck Sharp & Dohme LLC $143.50 8 $0 (2023)
EISAI INC. $112.24 6 $0 (2022)
Daiichi Sankyo Inc. $108.98 6 $0 (2022)
TerSera Therapeutics LLC $108.10 7 $0 (2021)
Bayer Healthcare Pharmaceuticals Inc. $99.50 7 $0 (2023)
BeiGene USA, Inc. $99.37 4 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $190.03 8 Celgene Corporation ($76.82)
2023 $316.37 18 Celgene Corporation ($61.50)
2022 $595.22 30 Pharmacyclics LLC, an AbbVie Company ($101.40)
2021 $342.18 19 BeiGene USA, Inc. ($51.55)
2020 $130.86 9 Amgen Inc. ($32.89)
2019 $370.49 22 Amgen Inc. ($61.29)
2018 $305.76 19 Pharmacyclics LLC, An AbbVie Company ($44.22)
2017 $322.13 22 Lexicon Pharmaceuticals, Inc. ($76.65)

All Payment Transactions

147 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
11/19/2024 Celgene Corporation OPDUALAG (Drug) Food and Beverage Cash or cash equivalent $19.33 General
Category: Oncology
09/19/2024 ABBVIE INC. IMBRUVICA (Drug), EPKINLY Food and Beverage In-kind items and services $34.56 General
Category: ONCOLOGY
09/13/2024 ABBVIE INC. IMBRUVICA (Drug), EPKINLY Food and Beverage In-kind items and services $33.75 General
Category: ONCOLOGY
09/11/2024 Celgene Corporation OPDUALAG (Drug) Food and Beverage Cash or cash equivalent $19.68 General
Category: Oncology
07/23/2024 Celgene Corporation OPDUALAG (Drug) Food and Beverage Cash or cash equivalent $20.16 General
Category: Oncology
07/22/2024 Novartis Pharmaceuticals Corporation LUTATHERA (Drug) Food and Beverage In-kind items and services $23.21 General
Category: Oncology
06/04/2024 Novartis Pharmaceuticals Corporation LUTATHERA (Drug) Food and Beverage In-kind items and services $21.69 General
Category: Oncology
02/22/2024 Celgene Corporation Pomalyst (Drug) Food and Beverage Cash or cash equivalent $17.65 General
Category: Hematology
10/05/2023 Celgene Corporation Pomalyst (Drug) Food and Beverage Cash or cash equivalent $21.97 General
Category: Hematology
08/21/2023 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $16.94 General
Category: ONCOLOGY
08/10/2023 AstraZeneca Pharmaceuticals LP IMFINZI (Biological) Food and Beverage In-kind items and services $16.10 General
Category: Oncology
07/20/2023 Genentech USA, Inc. Columvi (Biological), Lunsumio, Polivy Food and Beverage In-kind items and services $13.82 General
Category: BioOncology
06/22/2023 Celgene Corporation OPDUALAG (Drug) Food and Beverage Cash or cash equivalent $22.22 General
Category: Oncology
06/22/2023 Janssen Biotech, Inc. DARZALEX (Biological), TECVAYLI Food and Beverage In-kind items and services $14.19 General
Category: Oncology
06/08/2023 MorphoSys, US Inc. MONJUVI (Drug) Food and Beverage In-kind items and services $16.29 General
Category: Oncology
06/06/2023 JAZZ PHARMACEUTICALS INC. ZEPZELCA (Drug) Food and Beverage In-kind items and services $20.98 General
Category: HEMATOLOGY/ONCOLOGY
05/23/2023 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Food and Beverage In-kind items and services $16.52 General
Category: ONCOLOGY
05/11/2023 Incyte Corporation JAKAFI (Drug) Food and Beverage Cash or cash equivalent $15.15 General
Category: Hematology/Oncology
05/10/2023 Incyte Corporation JAKAFI (Drug) Food and Beverage Cash or cash equivalent $20.17 General
Category: Hematology/Oncology
03/28/2023 Novartis Pharmaceuticals Corporation PLUVICTO (Drug) Food and Beverage In-kind items and services $21.16 General
Category: Oncology
03/16/2023 Janssen Biotech, Inc. — Food and Beverage In-kind items and services $25.91 General
03/16/2023 Celgene Corporation OPDUALAG (Drug) Food and Beverage Cash or cash equivalent $17.31 General
Category: Oncology
02/02/2023 GlaxoSmithKline, LLC. — Food and Beverage In-kind items and services $15.20 General
01/19/2023 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug), Xofigo Food and Beverage In-kind items and services $13.16 General
Category: Oncology
01/05/2023 Merck Sharp & Dohme LLC KEYTRUDA (Biological), LYNPARZA Food and Beverage In-kind items and services $14.29 General
Category: ONCOLOGY
123…6»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 19 568 8,509 $889,360 $187,317
2022 28 1,226 10,804 $2.1M $438,549
2021 29 1,503 15,330 $3.1M $659,317
2020 32 1,688 16,286 $4.0M $830,502
Total Patients
4,985
Total Services
50,929
Medicare Billing
$2.1M
Procedure Codes
109

All Medicare Procedures & Services

109 procedure records from CMS Medicare Utilization — Page 1 of 5

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
G6015 Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session Office 2023 91 232 $341,003 $60,578 17.8%
G0340 Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatme Office 2023 14 16 $122,304 $28,520 23.3%
77014 Ct guidance for insertion of radiation therapy fields Office 2023 96 242 $65,456 $21,240 32.4%
G6013 Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev Office 2023 42 85 $80,240 $14,238 17.7%
78815 Nuclear medicine study from skull base to mid-thigh with ct scan Office 2023 15 15 $32,944 $11,567 35.1%
77427 Radiation treatment management, 5 treatment sessions Office 2023 51 74 $55,944 $10,653 19.0%
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Office 2023 12 12 $9,600 $7,021 73.1%
G6012 Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev Office 2023 21 38 $31,826 $6,306 19.8%
77334 Design and construction of complex radiation treatment device Office 2023 26 55 $21,192 $4,733 22.3%
74178 Ct scan of abdomen and pelvis before and after contrast Office 2023 26 26 $21,736 $4,156 19.1%
77336 Continuing radiation therapy consultation per week Office 2023 14 63 $31,437 $3,958 12.6%
77280 Obtaining data needed to develop the optimal radiation treatment, 1 treatment area Office 2023 11 14 $10,360 $2,763 26.7%
77300 Calculation of radiation therapy dose Office 2023 13 54 $19,710 $2,667 13.5%
74177 Ct scan of abdomen and pelvis with contrast Office 2023 18 18 $8,712 $2,521 28.9%
77263 Complex radiation therapy planning Office 2023 13 14 $17,122 $1,820 10.6%
71260 Ct scan of chest with contrast Office 2023 21 21 $9,870 $1,703 17.3%
74176 Ct scan of abdomen and pelvis without contrast Office 2023 14 14 $3,556 $1,074 30.2%
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Office 2023 59 7,500 $1,875 $973.52 51.9%
G6002 Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy Office 2023 11 16 $4,473 $825.90 18.5%
G6015 Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session Office 2022 179 434 $637,911 $117,333 18.4%
G0340 Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatme Office 2022 29 36 $275,184 $69,396 25.2%
77014 Ct guidance for insertion of radiation therapy fields Office 2022 192 461 $124,691 $41,406 33.2%
G0339 Image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment Office 2022 12 12 $135,120 $31,472 23.3%
G6013 Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev Office 2022 78 165 $155,760 $29,443 18.9%
77427 Radiation treatment management, 5 treatment sessions Office 2022 104 144 $108,864 $21,088 19.4%
123…5»

About Dr. Douglas Ditzel, DO

Dr. Douglas Ditzel, DO is a Radiation Oncology healthcare provider based in Englewood, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154381747.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Douglas Ditzel, DO has received a total of $2,573 in payments from pharmaceutical and medical device companies, with $190.03 received in 2024. These payments were reported across 147 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($2,573).

As a Medicare-enrolled provider, Ditzel has provided services to 4,985 Medicare beneficiaries, totaling 50,929 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 109 distinct procedure/service records.

Practice Information

  • Specialty Radiation Oncology
  • Other Specialties Radiation Oncology
  • Location Englewood, OH
  • Active Since 03/27/2006
  • Last Updated 01/05/2022
  • Taxonomy Code 2085R0001X
  • Entity Type Individual
  • NPI Number 1154381747

Products in Payments

  • IMBRUVICA (Drug) $202.07
  • KEYTRUDA (Biological) $143.50
  • Lenvima (Drug) $112.24
  • Imbruvica (Drug) $100.84
  • BRUKINSA (Drug) $99.37
  • Xermelo (Drug) $99.05
  • OPDUALAG (Drug) $98.70
  • JAKAFI (Drug) $98.13
  • ZOLADEX (Drug) $85.70
  • Kyprolis (Biological) $68.23
  • Pomalyst (Drug) $51.62
  • Neulasta (Biological) $48.52
  • INJECTAFER (Drug) $48.32
  • Stivarga (Drug) $46.96
  • ERBITUX (Drug) $46.90
  • MEKINIST (Drug) $45.86
  • IMFINZI (Biological) $45.28
  • LUTATHERA (Drug) $44.90
  • Kyprolis (Drug) $44.47
  • ICLUSIG (Drug) $43.50

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Radiation Oncology Doctors in Englewood

Dr. Gregory Rasp, Md, MD

Radiation Oncology — Payments: $3,982

Radiation Oncology $3,982

Guy Savir, Md, MD

Radiation Oncology — Payments: $3,462

Radiation Oncology $3,462

Mei Zhang, Md, MD

Radiation Oncology — Payments: $3,274

Radiation Oncology $3,274

Trevor Bluemel, Md, MD

Radiation Oncology — Payments: $1,445

Radiation Oncology $1,445

David Dubin, Md, MD

Radiation Oncology — Payments: $1,198

Radiation Oncology $1,198

Jeffrey Gilroy, Md, MD

Radiation Oncology — Payments: $873.55

Radiation Oncology $873.55